0

Close
 
Upcoming Allied Market Research
2023
Protein Assays Market

Protein Assays Market

by Type (Dye Binding Protein Assays (Bradford), Copper Ions Based Protein Assays (Lowry) Test, Strip Based Protein Assay, Others), by Product (Instruments, Consumables), by Technology (Colorimetric Protein Assays, Absorbance-Based Protein Assays, Fluorescence-Based Protein Assays), by Application (Drug Discovery Development, Protein Purification, Disease Diagnosis, Others) and by End User (Pharmaceutical Industry, Biotechnology Companies, Hospitals, Clinical Laboratories, Research Institutes): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Diagnostics and Biotech
Report Code: A06187
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Protein Assays Market

Request Now !

Protein assay is an analytical technique used to determine protein concentration. The measurement of protein concentration is often necessary before processing protein samples for isolation, separation, and analysis by chromatographic, electrophoretic, and immunochemical techniques. There are various types of protein assays available for quantitation of protein and each of the assays has its own advantages and limitations. It is often necessary to obtain more than one type of protein assay for research applications. Various assays available in the market differ from each other on the basis of sensitivity, principle, and methodology. The protein assay finds its application in various areas including drug discovery, disease diagnosis, and protein purification. As more researchers explore different protein quantitation techniques, rapid, precise and reproducible protein assays empower researchers to discover new ways to diagnose diseases.

The global protein assays market is expected to register a substantial growth in the near future owing thigh demand in numerous applications of various stages of pre-clinical, clinical trial, and later stage of drug development. Moreover, high investment across various private & government funded R & D programs, and overall increased spending on R & D by pharmaceutical and biopharmaceutical industries supplement the growth of the protein assay market. However, high infrastructure cost and lack of trained resources restrain the growth of the protein assays market. In contrast, innovative technical developments in protein assay products and increase in demand for better and cost-effective methods for drug discovery and clinical trials are anticipated to provide lucrative opportunities for the growth of the market.

The protein assays market is segmented on the basis of type, product, technology, application, and end user. By type, the market is segmented into dye binding protein assays (Bradford), copper ions based protein assays (Lowry), test strip based protein assay, and others. By product, the market is characterized into instruments and consumables. The technologies covered in the study include colorimetric protein assays, absorbance-based protein assays, and fluorescence-based protein assays. By application, the market is segmented into drug discovery & development, protein purification, disease diagnosis, and others. By end user, the market is categorized into pharmaceutical companies, biotechnology companies, hospitals, clinical laboratories, and research institutes. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

The report provides a comprehensive analysis of the key players of the protein assays market including Thermo Fischer Scientific, Inc., Qiagen N.V., Abcam plc, Merck KGaA,PerkinElmer Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., General Electric (GE Healthcare), Takara Bio Inc., and F. Hoffmann-La Roche Ltd. Other players in the value chain include Lucigen Corporation, Cell Signaling Technology Inc., Lonza Group Ltd., BioVision Inc., Promega Corporation, and others. 

Key Benefits For Stakeholders

  • This report provides a detailed quantitative analysis of the current protein assays market trends and future estimations which assists to identify the prevailing opportunities. 

  • An in-depth protein assays market analysis includes various countries, and is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate country-specific plans.

  • A comprehensive analysis of the factors that drive and restrain the growth of the global protein assays market is provided.

  • Region-wise market conditions are comprehensively analyzed in this report.

  • An extensive analysis of various countries provides insights that are expected to allow companies to strategically plan their business moves.

  • Key market players within the protein assays market are profiled in this report and their strategies are analyzed thoroughly, which help to understand the competitive outlook of the market.  

 Protein Assays Market Report Highlights

Aspects Details
By Type
  • Dye Binding Protein Assays (Bradford)
  • Copper Ions Based Protein Assays (Lowry) Test
  • Strip Based Protein Assay
  • Others
By Product
  • Instruments
  • Consumables
By Technology
  • Colorimetric Protein Assays
  • Absorbance-Based Protein Assays
  • Fluorescence-Based Protein Assays
By Application
  • Drug Discovery & Development
  • Protein Purification
  • Disease Diagnosis
  • Others
By End User
  • Pharmaceutical Industry
  • Biotechnology Companies
  • Hospitals
  • Clinical Laboratories
  • Research Institutes
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players General Electric (GE Healthcare), Merck KGaA, PerkinElmer Inc., Qiagen N.V., Illumina Inc., Bio-Rad Laboratories Inc., Takara Bio Inc., Abcam plc, F. Hoffmann-La Roche Ltd, Thermo Fischer Scientific Inc.
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: PROTEIN ASSAYS MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Dye Binding Protein Assays (Bradford)

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Copper Ions Based Protein Assays (Lowry) Test

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Strip Based Protein Assay

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Others

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: PROTEIN ASSAYS MARKET, BY PRODUCT

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Product

    • 5.2. Instruments

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Consumables

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: PROTEIN ASSAYS MARKET, BY TECHNOLOGY

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Technology

    • 6.2. Colorimetric Protein Assays

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Absorbance-Based Protein Assays

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Fluorescence-Based Protein Assays

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: PROTEIN ASSAYS MARKET, BY APPLICATION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Application

    • 7.2. Drug Discovery Development

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Protein Purification

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Disease Diagnosis

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

    • 7.5. Others

      • 7.5.1. Key Market Trends, Growth Factors and Opportunities

      • 7.5.2. Market Size and Forecast, By Region

      • 7.5.3. Market Share Analysis, By Country

  • CHAPTER 8: PROTEIN ASSAYS MARKET, BY END USER

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By End User

    • 8.2. Pharmaceutical Industry

      • 8.2.1. Key Market Trends, Growth Factors and Opportunities

      • 8.2.2. Market Size and Forecast, By Region

      • 8.2.3. Market Share Analysis, By Country

    • 8.3. Biotechnology Companies

      • 8.3.1. Key Market Trends, Growth Factors and Opportunities

      • 8.3.2. Market Size and Forecast, By Region

      • 8.3.3. Market Share Analysis, By Country

    • 8.4. Hospitals

      • 8.4.1. Key Market Trends, Growth Factors and Opportunities

      • 8.4.2. Market Size and Forecast, By Region

      • 8.4.3. Market Share Analysis, By Country

    • 8.5. Clinical Laboratories

      • 8.5.1. Key Market Trends, Growth Factors and Opportunities

      • 8.5.2. Market Size and Forecast, By Region

      • 8.5.3. Market Share Analysis, By Country

    • 8.6. Research Institutes

      • 8.6.1. Key Market Trends, Growth Factors and Opportunities

      • 8.6.2. Market Size and Forecast, By Region

      • 8.6.3. Market Share Analysis, By Country

  • CHAPTER 9: PROTEIN ASSAYS MARKET, BY REGION

    • 9.1. Market Overview

      • 9.1.1 Market Size and Forecast, By Region

    • 9.2. North America

      • 9.2.1. Key Market Trends and Opportunities

      • 9.2.2. Market Size and Forecast, By Type

      • 9.2.3. Market Size and Forecast, By Product

      • 9.2.4. Market Size and Forecast, By Technology

      • 9.2.5. Market Size and Forecast, By Application

      • 9.2.6. Market Size and Forecast, By End User

      • 9.2.7. Market Size and Forecast, By Country

      • 9.2.8. U.S. Protein Assays Market

        • 9.2.8.1. Market Size and Forecast, By Type
        • 9.2.8.2. Market Size and Forecast, By Product
        • 9.2.8.3. Market Size and Forecast, By Technology
        • 9.2.8.4. Market Size and Forecast, By Application
        • 9.2.8.5. Market Size and Forecast, By End User

      • 9.2.9. Canada Protein Assays Market

        • 9.2.9.1. Market Size and Forecast, By Type
        • 9.2.9.2. Market Size and Forecast, By Product
        • 9.2.9.3. Market Size and Forecast, By Technology
        • 9.2.9.4. Market Size and Forecast, By Application
        • 9.2.9.5. Market Size and Forecast, By End User

      • 9.2.10. Mexico Protein Assays Market

        • 9.2.10.1. Market Size and Forecast, By Type
        • 9.2.10.2. Market Size and Forecast, By Product
        • 9.2.10.3. Market Size and Forecast, By Technology
        • 9.2.10.4. Market Size and Forecast, By Application
        • 9.2.10.5. Market Size and Forecast, By End User

    • 9.3. Europe

      • 9.3.1. Key Market Trends and Opportunities

      • 9.3.2. Market Size and Forecast, By Type

      • 9.3.3. Market Size and Forecast, By Product

      • 9.3.4. Market Size and Forecast, By Technology

      • 9.3.5. Market Size and Forecast, By Application

      • 9.3.6. Market Size and Forecast, By End User

      • 9.3.7. Market Size and Forecast, By Country

      • 9.3.8. France Protein Assays Market

        • 9.3.8.1. Market Size and Forecast, By Type
        • 9.3.8.2. Market Size and Forecast, By Product
        • 9.3.8.3. Market Size and Forecast, By Technology
        • 9.3.8.4. Market Size and Forecast, By Application
        • 9.3.8.5. Market Size and Forecast, By End User

      • 9.3.9. Germany Protein Assays Market

        • 9.3.9.1. Market Size and Forecast, By Type
        • 9.3.9.2. Market Size and Forecast, By Product
        • 9.3.9.3. Market Size and Forecast, By Technology
        • 9.3.9.4. Market Size and Forecast, By Application
        • 9.3.9.5. Market Size and Forecast, By End User

      • 9.3.10. Italy Protein Assays Market

        • 9.3.10.1. Market Size and Forecast, By Type
        • 9.3.10.2. Market Size and Forecast, By Product
        • 9.3.10.3. Market Size and Forecast, By Technology
        • 9.3.10.4. Market Size and Forecast, By Application
        • 9.3.10.5. Market Size and Forecast, By End User

      • 9.3.11. Spain Protein Assays Market

        • 9.3.11.1. Market Size and Forecast, By Type
        • 9.3.11.2. Market Size and Forecast, By Product
        • 9.3.11.3. Market Size and Forecast, By Technology
        • 9.3.11.4. Market Size and Forecast, By Application
        • 9.3.11.5. Market Size and Forecast, By End User

      • 9.3.12. UK Protein Assays Market

        • 9.3.12.1. Market Size and Forecast, By Type
        • 9.3.12.2. Market Size and Forecast, By Product
        • 9.3.12.3. Market Size and Forecast, By Technology
        • 9.3.12.4. Market Size and Forecast, By Application
        • 9.3.12.5. Market Size and Forecast, By End User

      • 9.3.13. Russia Protein Assays Market

        • 9.3.13.1. Market Size and Forecast, By Type
        • 9.3.13.2. Market Size and Forecast, By Product
        • 9.3.13.3. Market Size and Forecast, By Technology
        • 9.3.13.4. Market Size and Forecast, By Application
        • 9.3.13.5. Market Size and Forecast, By End User

      • 9.3.14. Rest Of Europe Protein Assays Market

        • 9.3.14.1. Market Size and Forecast, By Type
        • 9.3.14.2. Market Size and Forecast, By Product
        • 9.3.14.3. Market Size and Forecast, By Technology
        • 9.3.14.4. Market Size and Forecast, By Application
        • 9.3.14.5. Market Size and Forecast, By End User

    • 9.4. Asia-Pacific

      • 9.4.1. Key Market Trends and Opportunities

      • 9.4.2. Market Size and Forecast, By Type

      • 9.4.3. Market Size and Forecast, By Product

      • 9.4.4. Market Size and Forecast, By Technology

      • 9.4.5. Market Size and Forecast, By Application

      • 9.4.6. Market Size and Forecast, By End User

      • 9.4.7. Market Size and Forecast, By Country

      • 9.4.8. China Protein Assays Market

        • 9.4.8.1. Market Size and Forecast, By Type
        • 9.4.8.2. Market Size and Forecast, By Product
        • 9.4.8.3. Market Size and Forecast, By Technology
        • 9.4.8.4. Market Size and Forecast, By Application
        • 9.4.8.5. Market Size and Forecast, By End User

      • 9.4.9. Japan Protein Assays Market

        • 9.4.9.1. Market Size and Forecast, By Type
        • 9.4.9.2. Market Size and Forecast, By Product
        • 9.4.9.3. Market Size and Forecast, By Technology
        • 9.4.9.4. Market Size and Forecast, By Application
        • 9.4.9.5. Market Size and Forecast, By End User

      • 9.4.10. India Protein Assays Market

        • 9.4.10.1. Market Size and Forecast, By Type
        • 9.4.10.2. Market Size and Forecast, By Product
        • 9.4.10.3. Market Size and Forecast, By Technology
        • 9.4.10.4. Market Size and Forecast, By Application
        • 9.4.10.5. Market Size and Forecast, By End User

      • 9.4.11. South Korea Protein Assays Market

        • 9.4.11.1. Market Size and Forecast, By Type
        • 9.4.11.2. Market Size and Forecast, By Product
        • 9.4.11.3. Market Size and Forecast, By Technology
        • 9.4.11.4. Market Size and Forecast, By Application
        • 9.4.11.5. Market Size and Forecast, By End User

      • 9.4.12. Australia Protein Assays Market

        • 9.4.12.1. Market Size and Forecast, By Type
        • 9.4.12.2. Market Size and Forecast, By Product
        • 9.4.12.3. Market Size and Forecast, By Technology
        • 9.4.12.4. Market Size and Forecast, By Application
        • 9.4.12.5. Market Size and Forecast, By End User

      • 9.4.13. Thailand Protein Assays Market

        • 9.4.13.1. Market Size and Forecast, By Type
        • 9.4.13.2. Market Size and Forecast, By Product
        • 9.4.13.3. Market Size and Forecast, By Technology
        • 9.4.13.4. Market Size and Forecast, By Application
        • 9.4.13.5. Market Size and Forecast, By End User

      • 9.4.14. Malaysia Protein Assays Market

        • 9.4.14.1. Market Size and Forecast, By Type
        • 9.4.14.2. Market Size and Forecast, By Product
        • 9.4.14.3. Market Size and Forecast, By Technology
        • 9.4.14.4. Market Size and Forecast, By Application
        • 9.4.14.5. Market Size and Forecast, By End User

      • 9.4.15. Indonesia Protein Assays Market

        • 9.4.15.1. Market Size and Forecast, By Type
        • 9.4.15.2. Market Size and Forecast, By Product
        • 9.4.15.3. Market Size and Forecast, By Technology
        • 9.4.15.4. Market Size and Forecast, By Application
        • 9.4.15.5. Market Size and Forecast, By End User

      • 9.4.16. Rest of Asia Pacific Protein Assays Market

        • 9.4.16.1. Market Size and Forecast, By Type
        • 9.4.16.2. Market Size and Forecast, By Product
        • 9.4.16.3. Market Size and Forecast, By Technology
        • 9.4.16.4. Market Size and Forecast, By Application
        • 9.4.16.5. Market Size and Forecast, By End User

    • 9.5. LAMEA

      • 9.5.1. Key Market Trends and Opportunities

      • 9.5.2. Market Size and Forecast, By Type

      • 9.5.3. Market Size and Forecast, By Product

      • 9.5.4. Market Size and Forecast, By Technology

      • 9.5.5. Market Size and Forecast, By Application

      • 9.5.6. Market Size and Forecast, By End User

      • 9.5.7. Market Size and Forecast, By Country

      • 9.5.8. Brazil Protein Assays Market

        • 9.5.8.1. Market Size and Forecast, By Type
        • 9.5.8.2. Market Size and Forecast, By Product
        • 9.5.8.3. Market Size and Forecast, By Technology
        • 9.5.8.4. Market Size and Forecast, By Application
        • 9.5.8.5. Market Size and Forecast, By End User

      • 9.5.9. South Africa Protein Assays Market

        • 9.5.9.1. Market Size and Forecast, By Type
        • 9.5.9.2. Market Size and Forecast, By Product
        • 9.5.9.3. Market Size and Forecast, By Technology
        • 9.5.9.4. Market Size and Forecast, By Application
        • 9.5.9.5. Market Size and Forecast, By End User

      • 9.5.10. Saudi Arabia Protein Assays Market

        • 9.5.10.1. Market Size and Forecast, By Type
        • 9.5.10.2. Market Size and Forecast, By Product
        • 9.5.10.3. Market Size and Forecast, By Technology
        • 9.5.10.4. Market Size and Forecast, By Application
        • 9.5.10.5. Market Size and Forecast, By End User

      • 9.5.11. UAE Protein Assays Market

        • 9.5.11.1. Market Size and Forecast, By Type
        • 9.5.11.2. Market Size and Forecast, By Product
        • 9.5.11.3. Market Size and Forecast, By Technology
        • 9.5.11.4. Market Size and Forecast, By Application
        • 9.5.11.5. Market Size and Forecast, By End User

      • 9.5.12. Argentina Protein Assays Market

        • 9.5.12.1. Market Size and Forecast, By Type
        • 9.5.12.2. Market Size and Forecast, By Product
        • 9.5.12.3. Market Size and Forecast, By Technology
        • 9.5.12.4. Market Size and Forecast, By Application
        • 9.5.12.5. Market Size and Forecast, By End User

      • 9.5.13. Rest of LAMEA Protein Assays Market

        • 9.5.13.1. Market Size and Forecast, By Type
        • 9.5.13.2. Market Size and Forecast, By Product
        • 9.5.13.3. Market Size and Forecast, By Technology
        • 9.5.13.4. Market Size and Forecast, By Application
        • 9.5.13.5. Market Size and Forecast, By End User

  • CHAPTER 10: COMPETITIVE LANDSCAPE

    • 10.1. Introduction

    • 10.2. Top Winning Strategies

    • 10.3. Product Mapping Of Top 10 Player

    • 10.4. Competitive Dashboard

    • 10.5. Competitive Heatmap

    • 10.6. Top Player Positioning,2022

  • CHAPTER 11: COMPANY PROFILES

    • 11.1. Thermo Fischer Scientific Inc.

      • 11.1.1. Company Overview

      • 11.1.2. Key Executives

      • 11.1.3. Company Snapshot

      • 11.1.4. Operating Business Segments

      • 11.1.5. Product Portfolio

      • 11.1.6. Business Performance

      • 11.1.7. Key Strategic Moves and Developments

    • 11.2. Qiagen N.V.

      • 11.2.1. Company Overview

      • 11.2.2. Key Executives

      • 11.2.3. Company Snapshot

      • 11.2.4. Operating Business Segments

      • 11.2.5. Product Portfolio

      • 11.2.6. Business Performance

      • 11.2.7. Key Strategic Moves and Developments

    • 11.3. Abcam Plc

      • 11.3.1. Company Overview

      • 11.3.2. Key Executives

      • 11.3.3. Company Snapshot

      • 11.3.4. Operating Business Segments

      • 11.3.5. Product Portfolio

      • 11.3.6. Business Performance

      • 11.3.7. Key Strategic Moves and Developments

    • 11.4. Merck KGaA

      • 11.4.1. Company Overview

      • 11.4.2. Key Executives

      • 11.4.3. Company Snapshot

      • 11.4.4. Operating Business Segments

      • 11.4.5. Product Portfolio

      • 11.4.6. Business Performance

      • 11.4.7. Key Strategic Moves and Developments

    • 11.5. PerkinElmer Inc.

      • 11.5.1. Company Overview

      • 11.5.2. Key Executives

      • 11.5.3. Company Snapshot

      • 11.5.4. Operating Business Segments

      • 11.5.5. Product Portfolio

      • 11.5.6. Business Performance

      • 11.5.7. Key Strategic Moves and Developments

    • 11.6. Bio-Rad Laboratories Inc.

      • 11.6.1. Company Overview

      • 11.6.2. Key Executives

      • 11.6.3. Company Snapshot

      • 11.6.4. Operating Business Segments

      • 11.6.5. Product Portfolio

      • 11.6.6. Business Performance

      • 11.6.7. Key Strategic Moves and Developments

    • 11.7. Illumina Inc.

      • 11.7.1. Company Overview

      • 11.7.2. Key Executives

      • 11.7.3. Company Snapshot

      • 11.7.4. Operating Business Segments

      • 11.7.5. Product Portfolio

      • 11.7.6. Business Performance

      • 11.7.7. Key Strategic Moves and Developments

    • 11.8. General Electric (GE Healthcare)

      • 11.8.1. Company Overview

      • 11.8.2. Key Executives

      • 11.8.3. Company Snapshot

      • 11.8.4. Operating Business Segments

      • 11.8.5. Product Portfolio

      • 11.8.6. Business Performance

      • 11.8.7. Key Strategic Moves and Developments

    • 11.9. Takara Bio Inc.

      • 11.9.1. Company Overview

      • 11.9.2. Key Executives

      • 11.9.3. Company Snapshot

      • 11.9.4. Operating Business Segments

      • 11.9.5. Product Portfolio

      • 11.9.6. Business Performance

      • 11.9.7. Key Strategic Moves and Developments

    • 11.10. F. Hoffmann-La Roche Ltd

      • 11.10.1. Company Overview

      • 11.10.2. Key Executives

      • 11.10.3. Company Snapshot

      • 11.10.4. Operating Business Segments

      • 11.10.5. Product Portfolio

      • 11.10.6. Business Performance

      • 11.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL PROTEIN ASSAYS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL PROTEIN ASSAYS MARKET FOR DYE BINDING PROTEIN ASSAYS (BRADFORD), BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL PROTEIN ASSAYS MARKET FOR COPPER IONS BASED PROTEIN ASSAYS (LOWRY) TEST, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL PROTEIN ASSAYS MARKET FOR STRIP BASED PROTEIN ASSAY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL PROTEIN ASSAYS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL PROTEIN ASSAYS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL PROTEIN ASSAYS MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL PROTEIN ASSAYS MARKET FOR CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL PROTEIN ASSAYS MARKET FOR COLORIMETRIC PROTEIN ASSAYS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL PROTEIN ASSAYS MARKET FOR ABSORBANCE-BASED PROTEIN ASSAYS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL PROTEIN ASSAYS MARKET FOR FLUORESCENCE-BASED PROTEIN ASSAYS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL PROTEIN ASSAYS MARKET FOR DRUG DISCOVERY DEVELOPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL PROTEIN ASSAYS MARKET FOR PROTEIN PURIFICATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL PROTEIN ASSAYS MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL PROTEIN ASSAYS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL PROTEIN ASSAYS MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. GLOBAL PROTEIN ASSAYS MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. GLOBAL PROTEIN ASSAYS MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. GLOBAL PROTEIN ASSAYS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 23. GLOBAL PROTEIN ASSAYS MARKET FOR RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 24. GLOBAL PROTEIN ASSAYS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA PROTEIN ASSAYS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 26. NORTH AMERICA PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 27. NORTH AMERICA PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 28. NORTH AMERICA PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 29. NORTH AMERICA PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. NORTH AMERICA PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 31. U.S. PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 32. U.S. PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 33. U.S. PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 34. U.S. PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. U.S. PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. CANADA PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 37. CANADA PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 38. CANADA PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 39. CANADA PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 40. CANADA PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 41. MEXICO PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 42. MEXICO PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 43. MEXICO PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 44. MEXICO PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. MEXICO PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. EUROPE PROTEIN ASSAYS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 47. EUROPE PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 48. EUROPE PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 49. EUROPE PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 50. EUROPE PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 51. EUROPE PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. FRANCE PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 53. FRANCE PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 54. FRANCE PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 55. FRANCE PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 56. FRANCE PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 57. GERMANY PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 58. GERMANY PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 59. GERMANY PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 60. GERMANY PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 61. GERMANY PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. ITALY PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 63. ITALY PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 64. ITALY PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 65. ITALY PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. ITALY PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. SPAIN PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 68. SPAIN PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 69. SPAIN PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 70. SPAIN PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 71. SPAIN PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 72. UK PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 73. UK PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 74. UK PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 75. UK PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 76. UK PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 77. RUSSIA PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 78. RUSSIA PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 79. RUSSIA PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 80. RUSSIA PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 81. RUSSIA PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 82. REST OF EUROPE PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 83. REST OF EUROPE PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 84. REST OF EUROPE PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 85. REST OF EUROPE PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 86. REST OF EUROPE PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 87. ASIA-PACIFIC PROTEIN ASSAYS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 88. ASIA-PACIFIC PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 89. ASIA-PACIFIC PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 90. ASIA-PACIFIC PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 91. ASIA-PACIFIC PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 92. ASIA-PACIFIC PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 93. CHINA PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 94. CHINA PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 95. CHINA PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 96. CHINA PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 97. CHINA PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 98. JAPAN PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 99. JAPAN PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 100. JAPAN PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 101. JAPAN PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 102. JAPAN PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 103. INDIA PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 104. INDIA PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 105. INDIA PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 106. INDIA PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 107. INDIA PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 108. SOUTH KOREA PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 109. SOUTH KOREA PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 110. SOUTH KOREA PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 111. SOUTH KOREA PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 112. SOUTH KOREA PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 113. AUSTRALIA PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 114. AUSTRALIA PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 115. AUSTRALIA PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 116. AUSTRALIA PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 117. AUSTRALIA PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 118. THAILAND PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 119. THAILAND PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 120. THAILAND PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 121. THAILAND PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 122. THAILAND PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 123. MALAYSIA PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 124. MALAYSIA PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 125. MALAYSIA PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 126. MALAYSIA PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 127. MALAYSIA PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 128. INDONESIA PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 129. INDONESIA PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 130. INDONESIA PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 131. INDONESIA PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 132. INDONESIA PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 133. REST OF ASIA PACIFIC PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 134. REST OF ASIA PACIFIC PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 135. REST OF ASIA PACIFIC PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 136. REST OF ASIA PACIFIC PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 137. REST OF ASIA PACIFIC PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 138. LAMEA PROTEIN ASSAYS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 139. LAMEA PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 140. LAMEA PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 141. LAMEA PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 142. LAMEA PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 143. LAMEA PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 144. BRAZIL PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 145. BRAZIL PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 146. BRAZIL PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 147. BRAZIL PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 148. BRAZIL PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 149. SOUTH AFRICA PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 150. SOUTH AFRICA PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 151. SOUTH AFRICA PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 152. SOUTH AFRICA PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 153. SOUTH AFRICA PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 154. SAUDI ARABIA PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 155. SAUDI ARABIA PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 156. SAUDI ARABIA PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 157. SAUDI ARABIA PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 158. SAUDI ARABIA PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 159. UAE PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 160. UAE PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 161. UAE PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 162. UAE PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 163. UAE PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 164. ARGENTINA PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 165. ARGENTINA PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 166. ARGENTINA PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 167. ARGENTINA PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 168. ARGENTINA PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 169. REST OF LAMEA PROTEIN ASSAYS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 170. REST OF LAMEA PROTEIN ASSAYS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 171. REST OF LAMEA PROTEIN ASSAYS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 172. REST OF LAMEA PROTEIN ASSAYS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 173. REST OF LAMEA PROTEIN ASSAYS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 174. THERMO FISCHER SCIENTIFIC INC.: KEY EXECUTIVES
  • TABLE 175. THERMO FISCHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 176. THERMO FISCHER SCIENTIFIC INC.: OPERATING SEGMENTS
  • TABLE 177. THERMO FISCHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 178. THERMO FISCHER SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 179. QIAGEN N.V.: KEY EXECUTIVES
  • TABLE 180. QIAGEN N.V.: COMPANY SNAPSHOT
  • TABLE 181. QIAGEN N.V.: OPERATING SEGMENTS
  • TABLE 182. QIAGEN N.V.: PRODUCT PORTFOLIO
  • TABLE 183. QIAGEN N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 184. ABCAM PLC: KEY EXECUTIVES
  • TABLE 185. ABCAM PLC: COMPANY SNAPSHOT
  • TABLE 186. ABCAM PLC: OPERATING SEGMENTS
  • TABLE 187. ABCAM PLC: PRODUCT PORTFOLIO
  • TABLE 188. ABCAM PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 189. MERCK KGAA: KEY EXECUTIVES
  • TABLE 190. MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 191. MERCK KGAA: OPERATING SEGMENTS
  • TABLE 192. MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 193. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 194. PERKINELMER INC.: KEY EXECUTIVES
  • TABLE 195. PERKINELMER INC.: COMPANY SNAPSHOT
  • TABLE 196. PERKINELMER INC.: OPERATING SEGMENTS
  • TABLE 197. PERKINELMER INC.: PRODUCT PORTFOLIO
  • TABLE 198. PERKINELMER INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 199. BIO-RAD LABORATORIES INC.: KEY EXECUTIVES
  • TABLE 200. BIO-RAD LABORATORIES INC.: COMPANY SNAPSHOT
  • TABLE 201. BIO-RAD LABORATORIES INC.: OPERATING SEGMENTS
  • TABLE 202. BIO-RAD LABORATORIES INC.: PRODUCT PORTFOLIO
  • TABLE 203. BIO-RAD LABORATORIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 204. ILLUMINA INC.: KEY EXECUTIVES
  • TABLE 205. ILLUMINA INC.: COMPANY SNAPSHOT
  • TABLE 206. ILLUMINA INC.: OPERATING SEGMENTS
  • TABLE 207. ILLUMINA INC.: PRODUCT PORTFOLIO
  • TABLE 208. ILLUMINA INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 209. GENERAL ELECTRIC (GE HEALTHCARE): KEY EXECUTIVES
  • TABLE 210. GENERAL ELECTRIC (GE HEALTHCARE): COMPANY SNAPSHOT
  • TABLE 211. GENERAL ELECTRIC (GE HEALTHCARE): OPERATING SEGMENTS
  • TABLE 212. GENERAL ELECTRIC (GE HEALTHCARE): PRODUCT PORTFOLIO
  • TABLE 213. GENERAL ELECTRIC (GE HEALTHCARE): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 214. TAKARA BIO INC.: KEY EXECUTIVES
  • TABLE 215. TAKARA BIO INC.: COMPANY SNAPSHOT
  • TABLE 216. TAKARA BIO INC.: OPERATING SEGMENTS
  • TABLE 217. TAKARA BIO INC.: PRODUCT PORTFOLIO
  • TABLE 218. TAKARA BIO INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 219. F. HOFFMANN-LA ROCHE LTD: KEY EXECUTIVES
  • TABLE 220. F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
  • TABLE 221. F. HOFFMANN-LA ROCHE LTD: OPERATING SEGMENTS
  • TABLE 222. F. HOFFMANN-LA ROCHE LTD: PRODUCT PORTFOLIO
  • TABLE 223. F. HOFFMANN-LA ROCHE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL PROTEIN ASSAYS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL PROTEIN ASSAYS MARKET
  • FIGURE 3. SEGMENTATION PROTEIN ASSAYS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN PROTEIN ASSAYS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALPROTEIN ASSAYS MARKET
  • FIGURE 11. PROTEIN ASSAYS MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. PROTEIN ASSAYS MARKET FOR DYE BINDING PROTEIN ASSAYS (BRADFORD), BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. PROTEIN ASSAYS MARKET FOR COPPER IONS BASED PROTEIN ASSAYS (LOWRY) TEST, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. PROTEIN ASSAYS MARKET FOR STRIP BASED PROTEIN ASSAY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. PROTEIN ASSAYS MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. PROTEIN ASSAYS MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 17. PROTEIN ASSAYS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. PROTEIN ASSAYS MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. PROTEIN ASSAYS MARKET SEGMENTATION, BY BY TECHNOLOGY
  • FIGURE 20. PROTEIN ASSAYS MARKET FOR COLORIMETRIC PROTEIN ASSAYS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. PROTEIN ASSAYS MARKET FOR ABSORBANCE-BASED PROTEIN ASSAYS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. PROTEIN ASSAYS MARKET FOR FLUORESCENCE-BASED PROTEIN ASSAYS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. PROTEIN ASSAYS MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 24. PROTEIN ASSAYS MARKET FOR DRUG DISCOVERY DEVELOPMENT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. PROTEIN ASSAYS MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. PROTEIN ASSAYS MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 27. PROTEIN ASSAYS MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 28. PROTEIN ASSAYS MARKET SEGMENTATION, BY BY END USER
  • FIGURE 29. PROTEIN ASSAYS MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 30. PROTEIN ASSAYS MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 31. PROTEIN ASSAYS MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 32. PROTEIN ASSAYS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 33. PROTEIN ASSAYS MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 34. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 35. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 36. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 37. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 38. COMPETITIVE DASHBOARD
  • FIGURE 39. COMPETITIVE HEATMAP: PROTEIN ASSAYS MARKET
  • FIGURE 40. Top player positioning, 2022
  • FIGURE 41. THERMO FISCHER SCIENTIFIC INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 42. THERMO FISCHER SCIENTIFIC INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 43. THERMO FISCHER SCIENTIFIC INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 44. QIAGEN N.V.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 45. QIAGEN N.V.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 46. QIAGEN N.V.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 47. ABCAM PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 48. ABCAM PLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 49. ABCAM PLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 50. MERCK KGAA: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. MERCK KGAA: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 52. MERCK KGAA: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 53. PERKINELMER INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. PERKINELMER INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 55. PERKINELMER INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 56. BIO-RAD LABORATORIES INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 57. BIO-RAD LABORATORIES INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 58. BIO-RAD LABORATORIES INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 59. ILLUMINA INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 60. ILLUMINA INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 61. ILLUMINA INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 62. GENERAL ELECTRIC (GE HEALTHCARE): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 63. GENERAL ELECTRIC (GE HEALTHCARE): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 64. GENERAL ELECTRIC (GE HEALTHCARE): REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 65. TAKARA BIO INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 66. TAKARA BIO INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 67. TAKARA BIO INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 68. F. HOFFMANN-LA ROCHE LTD: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 69. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 70. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Protein Assays Market

Start reading.
This Report and over 66,983+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers